Federated Hermes’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.73M | Buy |
368,617
+13,670
| +4% | +$174K | 0.01% | 812 |
|
|
2025
Q4 | $3.19M | Buy |
354,947
+351,684
| +10,778% | +$4.84M | 0.01% | 864 |
|
|
2025
Q3 | $56.4K | Buy |
3,263
+927
| +40% | +$11.4K | ﹤0.01% | 1646 |
|
|
2025
Q2 | $21.9K | Sell |
2,336
-82
| -3% | -$673 | ﹤0.01% | 1701 |
|
|
2025
Q1 | $17.2K | Sell |
2,418
-1,427
| -37% | -$14.4K | ﹤0.01% | 1747 |
|
|
2024
Q4 | $44.8K | Sell |
3,845
-2,736,920
| -100% | -$42.7M | ﹤0.01% | 1700 |
|
|
2024
Q3 | $56.3M | Buy |
2,740,765
+439,876
| +19% | +$10.1M | 0.12% | 220 |
|
|
2024
Q2 | $51.5M | Buy |
2,300,889
+371,189
| +19% | +$8.84M | 0.12% | 215 |
|
|
2024
Q1 | $53.1M | Sell |
1,929,700
-86,600
| -4% | -$2.41M | 0.12% | 216 |
|
|
2023
Q4 | $61.5M | Buy |
2,016,300
+244,722
| +14% | +$7.03M | 0.15% | 172 |
|
|
2023
Q3 | $56M | Sell |
1,771,578
-248,501
| -12% | -$9.64M | 0.15% | 174 |
|
|
2023
Q2 | $82.4M | Hold |
2,020,079
| – | – | 0.2% | 107 |
|
|
2023
Q1 | $75.3M | Sell |
2,020,079
-86,566
| -4% | -$3.4M | 0.19% | 123 |
|
|
2022
Q4 | $73.5M | Buy |
2,106,645
+592,045
| +39% | +$28.2M | 0.2% | 110 |
|
|
2022
Q3 | $84.8M | Buy |
1,514,600
+96,300
| +7% | +$5.97M | 0.25% | 93 |
|
|
2022
Q2 | $73.4M | Buy |
1,418,300
+798,700
| +129% | +$40.6M | 0.2% | 129 |
|
|
2022
Q1 | $45M | Buy |
619,600
+69,210
| +13% | +$5.86M | 0.1% | 251 |
|
|
2021
Q4 | $65.1M | Sell |
550,390
-156,440
| -22% | -$19.6M | 0.12% | 220 |
|
|
2021
Q3 | $94.8M | Sell |
706,830
-46,192
| -6% | -$6.99M | 0.18% | 159 |
|
|
2021
Q2 | $122M | Buy |
753,022
+92,037
| +14% | +$7.17M | 0.23% | 116 |
|
|
2021
Q1 | $53M | Buy |
660,985
+161,626
| +32% | +$10.8M | 0.1% | 258 |
|
|
2020
Q4 | $27.2M | Buy |
499,359
+380,640
| +321% | +$13.8M | 0.06% | 387 |
|
|
2020
Q3 | $2.36M | Buy |
118,719
+42,328
| +55% | +$883K | 0.01% | 927 |
|
|
2020
Q2 | $1.61M | Buy |
+76,391
| New | +$1.3M | ﹤0.01% | 1070 |
|
|
2019
Q2 | – | Sell |
-667,000
| Closed | -$11.4M | – | 2200 |
|
|
2019
Q1 | $11.4M | Hold |
667,000
| – | – | 0.03% | 516 |
|
|
2018
Q4 | $9.11M | Sell |
667,000
-525
| -0.1% | -$9.76K | 0.03% | 529 |
|
|
2018
Q3 | $19.1M | Buy |
667,525
+42,225
| +7% | +$1.23M | 0.04% | 368 |
|
|
2018
Q2 | $17.1M | Buy |
625,300
+27,200
| +5% | +$659K | 0.05% | 297 |
|
|
2018
Q1 | $12.6M | Buy |
598,100
+198,100
| +50% | +$4.87M | 0.04% | 363 |
|
|
2017
Q4 | $7.69M | Buy |
+400,000
| New | +$9.23M | 0.02% | 489 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
